George Morrow is currently a Board Director at Neurocrine Biosciences and has held various leadership roles across the biotechnology and pharmaceutical sectors. They serve on the board of Align Technology, where they chair the Compensation and Benefits Committee, and have been a member of the boards of Vical and Otonomy, among others. Previously, Morrow was the President and CEO of Glaxo Wellcome Inc. and retired as Executive Vice President of Global Commercial Operations at Amgen. They earned an MBA from Duke University's Fuqua School of Business and hold a Master of Science in Biochemistry from Bryn Mawr College, as well as a Bachelor of Science in Chemistry from Long Island University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices